Biocon Biologics, a subsidiary of Biocon, on Monday got approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India ...
IBTmes India
6 days ago
CNBC Awaaz
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
The Economic Times
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
Biocon gets 4 observations from USFDA for Andhra facility - ET HealthWorld | Pharma
7 days ago
Livemint
Stocks to buy: Federal Bank, Biocon, among top picks by SMC Global for this week
5 days ago
Financial Express
Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹351.00 +4.85 (+1.40%)
Fri, Jun 28, 2024, 6:00AM EDT